Cell-Free DNA Analysis Distinguishes Recurrent From Primary Breast Cancer
Kumamoto University researchers have developed a blood test that analyzes nucleosome structures in cell-free DNA to detect breast cancer recurrence.
Tag: biomarkers
All
Latest
All
Latest
Caris Life Sciences Launches PTEN IHC Testing for Prostate Cancer
Caris Life Sciences has launched in-house PTEN IHC testing to identify prostate cancer patients eligible for FDA-approved, biomarker-guided therapy, supporting precision treatment for PTEN-deficient mAPMN/S prostate cancer.
All
Latest
Alamar Gains Rights to Develop Clinical Alzheimer’s Blood Tests Using ALZpath Antibody
ALZpath and Alamar Biosciences have expanded their partnership, granting Alamar commercial rights to use ALZpath’s pTau217 antibody in clinical blood tests for Alzheimer’s disease.
Beckman Coulter Receives CE Mark for Automated p-Tau217 Alzheimer’s Blood Test
The p-Tau217 assay runs on the DxI 9000 Immunoassay Analyzer, enabling laboratories to incorporate blood-based Alzheimer’s biomarker testing into high-throughput workflows.
Read More
Lilly to Present Data Comparing P-Tau217 Blood Tests With Amyloid PET at AAIC
Presentations at the upcoming Alzheimer’s Association International Conference include data comparing P-tau217 blood biomarker tests with amyloid PET, along with new long-term safety findings for donanemab.
Read More
FDA Clears New Heart Disease Risk Test for Clinical Labs
The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories.
Read More
Caris Life Sciences Launches New Blood Test for Early Cancer Detection
The test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read More
Blood Circular RNAs Outperform pTau217 in Predicting Alzheimer’s Disease Progression
A new NIH-funded study finds that elevated circular RNAs in blood may predict Alzheimer’s symptoms years in advance, outperforming current blood tests in forecasting disease progression.
Read More
Study Supports Prognostic Value of Alzheimer’s Biomarkers in Adults Over 80 With Mild Cognitive Impairment
Research indicates that blood and cerebrospinal fluid tests provide relevant prognostic information for elderly patients, challenging the idea that aging makes these tests less useful.
Read More
HerAnova Presents Validation Data for Endometriosis Blood Test
HerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read More
Studies Support Blood Tests for Assessing MASLD and MASH Risk
Labcorp studies report new blood-based tools, including the Metabolic Vulnerability Index, may improve risk assessment for MASLD and MASH, offering enhanced prediction of adverse liver outcomes, according to recent peer-reviewed research.
Read More
Labcorp Launches RNA-Based At-Home Colorectal Cancer Test Nationwide
The test detect signs of colorectal cancer and precancerous growths using a home collection kit.
Read More
AI Pathology Startup Expands Deployment of Cancer Diagnostic Platform
The company’s product, Slideflow Pro, is a scalable and modular platform designed to analyze digitized pathology slides and support the development of AI-based biomarkers that can help answer clinically important questions in cancer care.
Read More
New Study Links Biomarker Elevations to Kidney Transplant Failure Risk
Elevated donor-derived cell-free DNA levels are linked to higher kidney transplant failure risk, suggesting earlier detection of allograft injury before loss of kidney function.
Read More
Expanded Approval Broadens Use of Roche MMR Test for Immunotherapy Selection
The companion diagnostic evaluates mismatch repair deficiency, a predictive biomarker used to identify patients who may respond to PD-1-targeted therapies.
Read More
Blood Test Gains FDA Approval for First-Line HER2-Mutant Lung Cancer Treatment Selection
Guardant360 CDx can now identify patients eligible for zongertinib, the first targeted therapy approved as an initial treatment option for HER2-mutant advanced non-small cell lung cancer.
Read More
Liquid Biopsy Maps Tumor Microenvironment to Predict Immunotherapy Response
Mayo Clinic and Stanford Medicine researchers have developed a liquid biopsy that profiles tumor microenvironments to help predict immunotherapy response, according to a study published in Nature.
Read More
Can an Alzheimer’s Blood Test Detect Early, Subtle Cognitive Decline?
Biomarkers in midlife adults without dementia may be linked to the earliest signs of waning cognition, researchers found.
Read More